Browsing by Author "Salamero García, Olga"
Now showing items 1-5 of 5
-
Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial
Döhner, Hartmut; Symeonidis, Argiris; Deeren, Dries; Demeter, Judit; Sanz, Miguel A.; Anagnostopoulos, Achilles; Salamero García, Olga (Wolters Kluwer Health, 2021-08) -
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia
Salamero García, Olga; Willekens, Christophe; Pérez-Simón, José Antonio; Pigneux, Arnaud; Récher, Christian; Carpio Segura, Cecilia Carmen; Bosch Albareda, Francesc; Montesinos, Pau (American Society of Clinical Oncology, 2020-12-20) -
First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia
Boyiadzis, Michael; Desai, Pinkal; Daskalakis, Nikki; Donnellan, William; Ferrante, Lucille; Goldberg, Jenna D.; Salamero García, Olga (Wiley, 2023-03) -
Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study
Kayser, Sabine; Rahmé, Ramy; Martínez-Cuadrón, David; Ghiaur, Gabriel; Thomas, Xavier; Sobas, Marta; Salamero García, Olga (Springer Nature, 2020-09) -
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial
Ayala, Rosa; Rapado, Inmaculada; Onecha, Esther; Martínez-Cuadrón, David; Carreño-Tarragona, Gonzalo; Bergua, Juan Miguel; Salamero García, Olga (MDPI, 2021-05-18)